Kevin Rycyna
Urology · Pittsburgh, PANPI 1922330042
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $112 of the $136 with a category attached, or 82.4%. 6 manufacturers reported payments, led by Olympus America Inc. at 28.0% of the total. That places this record below the midpoint for urology clinicians in PA, where the typical reported total is $2,187.
Across 6 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$38
- Myovant Sciences Inc.$24
- Boston Scientific$24
- Procept Biorobotics Corporation$20
- Merck$17
- AbbVie$14
What the payments were for
- Food & beverage$11282%
- Education$2418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 1 | $38 |
| Myovant Sciences Inc. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Procept Biorobotics Corporation | 1 | $20 |
| Merck | 1 | $17 |
| AbbVie | 1 | $14 |
How this compares
$136 in reported general payments places this provider in the 10th percentile of 596 urology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 89 | $68,869 |
| Mirabegron ErMirabegron | 47 | $24,696 |
| Tamsulosin Hcl | 805 | $15,844 |
| Methenamine Hippurate | 89 | $9,646 |
| Potassium Citrate ErPotassium Citrate | 70 | $7,737 |
| Solifenacin Succinate | 100 | $6,178 |
| PremarinEstrogens, Conjugated | 14 | $5,925 |
| Finasteride | 287 | $3,929 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 160 | $3,128 |
| Testosterone | 18 | $2,787 |
| Fosfomycin Tromethamine | 13 | $2,486 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $1,677 |
| Trospium Chloride | 53 | $1,573 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 28 | $905 |
| Dutasteride | 26 | $693 |
Paid to pharmacies, not to this prescriber.
Other urology in Pittsburgh
- Quoc-Dien TrinhPittsburgh$111K
- Paul RusilkoPittsburgh$67K
- Kiran SuryPittsburgh$61K
- Michelle SeminsPittsburgh$31K
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Paul SieberLancaster$631K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.